Logo Logo
Eine Ebene nach oben
Exportieren als [RSS feed] RSS 1.0 [RSS2 feed] RSS 2.0
Gruppiert nach: Dokumententyp | Veröffentlichungsdatum
Anzahl der Publikationen: 33

Zeitschriftenartikel

Hadi, Indrawati; Reitz, Daniel; Bodensohn, Raphael; Roengvoraphoj, Olarn; Lietke, Stefanie; Niyazi, Maximilian; Tonn, Jörg-Christian; Belka, Claus; Thon, Niklas und Nachbichler, Silke Birgit (2021): Radiation necrosis after a combination of external beam radiotherapy and iodine-125 brachytherapy in gliomas. In: Radiation Oncology, Bd. 16, Nr. 1, 40

Eze, Chukwuka; Schmidt-Hegemann, Nina-Sophie; Sawicki, Lino Morris; Kirchner, Julian; Roengvoraphoj, Olarn; Kaesmann, Lukas; Mittlmeier, Lena M.; Kunz, Wolfgang G.; Tufman, Amanda; Dinkel, Julien; Ricke, Jens; Belka, Claus; Manapov, Farkhad und Unterrainer, Marcus (2021): PET/CT imaging for evaluation of multimodal treatment efficacy and toxicity in advanced NSCLC-current state and future directions. In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 48, Nr. 12: S. 3975-3989

Hadi, Indrawati; Reitz, Daniel; Bodensohn, Raphael; Roengvoraphoj, Olarn; Lietke, Stefanie; Niyazi, Maximilian; Tonn, Jörg-Christian; Belka, Claus ORCID logoORCID: https://orcid.org/0000-0002-1287-7825; Thon, Niklas und Nachbichler, Silke Birgit (2021): Radiation necrosis after a combination of external beam radiotherapy and iodine-125 brachytherapy in gliomas. In: Radiation oncology, Bd. 16, Nr. 1, 40 [PDF, 980kB]

Eze, Chukwuka; Schmidt-Hegemann, Nina-Sophie; Sawicki, Lino Morris; Kirchner, Julian; Roengvoraphoj, Olarn; Käsmann, Lukas; Mittlmeier, Lena M.; Kunz, Wolfgang G.; Tufman, Amanda; Dinkel, Julien; Ricke, Jens; Belka, Claus ORCID logoORCID: https://orcid.org/0000-0002-1287-7825; Manapov, Farkhad und Unterrainer, Marcus (2021): PET/CT imaging for evaluation of multimodal treatment efficacy and toxicity in advanced NSCLC-current state and future directions. In: European journal of nuclear medicine and molecular imaging [PDF, 3MB]

Manapov, Farkhad; Käsmann, Lukas; Roengvoraphoj, Olarn; Belka, Claus ORCID logoORCID: https://orcid.org/0000-0002-1287-7825 und Eze, Chukwuka ORCID logoORCID: https://orcid.org/0000-0003-3779-1398 (2020): Multimodal “synergistic” treatment based on tumour immunological contexture for advanced non‐driver non‐small cell lung cancer: A myth or reality? In: European Journal of Cancer Care, Bd. 29, Nr. 5 [PDF, 196kB]

Kaesmann, Lukas; Eze, Chukwuka; Taugner, Julian; Roengvoraphoj, Olarn; Dantes, Maurice; Schmidt-Hegemann, Nina-Sophie; Schiopu, Sanziana; Belka, Claus und Manapov, Farkhad (2020): Chemoradioimmunotherapy of inoperable stage III non-small cell lung cancer: immunological rationale and current clinical trials establishing a novel multimodal strategy. In: Radiation Oncology, Bd. 15, Nr. 1, 167

Karin, Monika; Taugner, Julian; Kaesmann, Lukas; Eze, Chukwuka; Roengvoraphoj, Olarn; Tufman, Amanda; Belka, Claus und Manapov, Farkhad (2020): Association of Planning Target Volume with Patient Outcome in Inoperable Stage III NSCLC Treated with Chemoradiotherapy: A Comprehensive Single-Center Analysis. In: Cancers, Bd. 12, Nr. 10, 3035

Hoffmann, Michael; Reitz, Daniel; Taugner, Julian; Roengvoraphoj, Olarn; Kaesmann, Lukas; Eze, Chukwuka; Karin, Monika; Belka, Claus und Manapov, Farkhad (2020): Blood Parameters Demonstrating a Significant Survival Impact in Patients With Locally Advanced NSCLC Undergoing Definitive Chemoradiotherapy. In: Anticancer Research, Bd. 40, Nr. 4: S. 2319-2322

Roengvoraphoj, Olarn; Kaesmann, Lukas; Eze, Chukwuka; Taugner, Julian; Gjika, Arteda; Tufman, Amanda; Hadi, Indrawati; Li, Minglun; Mille, Erik; Gennen, Kathrin; Belka, Claus und Manapov, Farkhad (2020): Maximum standardized uptake value of primary tumor (SUVmax_PT) and horizontal range between two most distant PET-positive lymph nodes predict patient outcome in inoperable stage III NSCLC patients after chemoradiotherapy. In: Translational Lung Cancer Research, Bd. 9, Nr. 3: S. 541-548

Kaesmann, Lukas; Eze, Chukwuka; Taugner, Julian; Roengvoraphoj, Olarn; Belka, Claus und Manapov, Farkhad (2020): Implementation of durvalumab maintenance treatment after concurrent chemoradiotherapy in inoperable stage III non-small cell lung cancer (NSCLC)-a German radiation oncology survey. In: Translational Lung Cancer Research, Bd. 9, Nr. 2: S. 288-293

Hadi, Indrawati; Roengvoraphoj, Olarn; Bodensohn, Raphael; Hofmaier, Jan; Niyazi, Maximilian; Belka, Claus und Nachbichler, Silke Birgit (2020): Stereotactic radiosurgery combined with targeted/ immunotherapy in patients with melanoma brain metastasis. In: Radiation Oncology, Bd. 15, Nr. 1, 37

Taugner, Julian; Eze, Chukwuka; Kaesmann, Lukas; Roengvoraphoj, Olarn; Gennen, Kathrin; Karin, Monika; Petrukhnov, Oleg; Tufman, Amanda; Belka, Claus und Manapov, Farkhad (2020): Pattern-of-failure and salvage treatment analysis after chemoradiotherapy for inoperable stage III non-small cell lung cancer. In: Radiation Oncology, Bd. 15, Nr. 1, 148

Gennen, Kathrin; Kaesmann, Lukas; Taugner, Julian; Eze, Chukwuka; Karin, Monika; Roengvoraphoj, Olarn; Neumann, Jens; Tufman, Amanda; Orth, Michael; Reu, Simone; Belka, Claus und Manapov, Farkhad (2020): Prognostic value of PD-L1 expression on tumor cells combined with CD8+TIL density in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy. In: Radiation Oncology, Bd. 15, Nr. 1, 5

Kaesmann, Lukas; Abdo, Reem; Eze, Chukwuka; Dantes, Maurice; Taugner, Julian; Gennen, Kathrin; Roengvoraphoj, Olarn; Rades, Dirk; Belka, Claus und Manapov, Farkhad (2020): External Validation of a Survival Score for Limited-Stage Small Cell Lung Cancer Patients Treated with Chemoradiotherapy. In: Lung, Bd. 198, Nr. 1: S. 201-206

Taugner, Julian; Kaesmann, Lukas; Eze, Chukwuka; Dantes, Maurice; Roengvoraphoj, Olarn; Gennen, Kathrin; Karin, Monika; Petruknov, Oleg; Tufman, Amanda; Belka, Claus und Manapov, Farkhad (2019): Survival score to characterize prognosis in inoperable stage III NSCLC after chemoradiotherapy. In: Translational Lung Cancer Research, Bd. 8, Nr. 5: S. 593-604

Eze, Chukwuka; Taugner, Julian; Roengvoraphoj, Olarn; Schmidt-Hegemann, Nina-Sophie; Kaesmann, Lukas; Wijaya, Cherylina; Belka, Claus und Manapov, Farkhad (2019): Initial report on feasibility of PET/CT-based image-guided moderate hypofractionated thoracic irradiation in node-positive non-small cell lung Cancer patients with poor prognostic factors and strongly diminished lung function: a retrospective analysis. In: Radiation Oncology, Bd. 14, Nr. 1, 163

Kaesmann, Lukas; Taugner, Julian; Eze, Chukwuka; Roengvoraphoj, Olarn; Dantes, Maurice; Gennen, Kathrin; Karin, Monika; Petrukhnov, Oleg; Tufman, Amanda; Belka, Claus und Manapov, Farkhad (2019): Performance Status and Its Changes Predict Outcome for Patients With Inoperable Stage III NSCLC Undergoing Multimodal Treatment. In: Anticancer Research, Bd. 39, Nr. 9: S. 5077-5081

Kaesmann, Lukas; Eze, Chukwuka; Dantes, Maurice; Roengvoraphoj, Olarn; Niyazi, Maximilian; Belka, Claus und Manapov, Farkhad (2019): State of clinical research of radiotherapy/chemoradiotherapy and immune checkpoint inhibitor therapy combinations in solid tumours-a German radiation oncology survey. In: European Journal of Cancer, Bd. 108: S. 50-54

Manapov, Farkhad; Käsmann, Lukas; Roengvoraphoj, Olarn; Dantes, Maurice; Schmidt-Hegemann, Nina-Sophie; Belka, Claus und Eze, Chukwuka (2018): Prophylactic cranial irradiation in small-cell lung cancer: update on patient selection, efficacy and outcomes. In: Lung Cancer-Targets and Therapy, Bd. 9: S. 49-55 [PDF, 163kB]

Roengvoraphoj, Olarn; Wijaya, Cherylina; Eze, Chukwuka; Li, Minglun; Dantes, Maurice; Taugner, Julian; Tufman, Amanda; Huber, Rudolf Maria; Belka, Claus und Manapov, Farkhad (2018): Analysis of primary tumor metabolic volume during chemoradiotherapy in locally advanced non-small cell lung cancer. In: Strahlentherapie und Onkologie, Bd. 194, Nr. 2: S. 107-115

Roengvoraphoj, Olarn; Eze, Chukwuka; Wijaya, Cherylina; Dantes, Maurice; Taugner, Julian; Tufman, Amanda; Huber, Rudolf Maria; Bartenstein, Peter; Belka, Claus und Manapov, Farkhad (2018): How much primary tumor metabolic volume reduction is required to improve outcome in stage III NSCLC after chemoradiotherapy? A single-centre experience. In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 45, Nr. 12: S. 2103-2109

Hadi, Indrawati; Roengvoraphoj, Olarn; Niyazi, Maximilian; Röder, Falk; Schüller, Ulrich; Belka, Claus und Nachbichler, Silke Birgit (2018): Medulloblastoma in adults. In: Strahlentherapie und Onkologie, Bd. 194, Nr. 3: S. 225-234

Manapov, Farkhad; Roengvoraphoj, Olarn; Dantes, Maurice; Marschner, Sebastian; Li, Minglun und Eze, Chukwuka (2018): Pneumonitis in Irradiated Lungs After Nivolumab: A Brief Communication and Review of the Literature. In: Journal of Immunotherapy, Bd. 41, Nr. 2: S. 96-99 [PDF, 174kB]

Eze, Chukwuka; Roengvoraphoj, Olarn; Dantes, Maurice; Abdo, Reem; Kaesmann, Lukas; Schmidt-Hegemann, Nina-Sophie; Belka, Claus und Manapov, Farkhad (2018): Prophylactic Cranial Irradiation for Patients with Small Cell Lung Cancer in Germany: Pattern of Care Survey. In: Anticancer Research, Bd. 38, Nr. 9: S. 5261-5265

Eze, Chukwuka; Roengvoraphoj, Olarn; Niyazi, Maximilian; Hildebrandt, Guido; Fietkau, Rainer; Belka, Claus und Manapov, Farkhad (2017): Treatment Response and Prophylactic Cranial Irradiation Are Important Prognostic Factors in LD SCLC Patients Staged with cMRI. In: Journal of thoracic Oncology, Bd. 12, Nr. 1: S1470-S1471

Eze, Chukwuka; Hegemann, Nina-Sophie; Roengvoraphoj, Olarn; Dantes, Maurice und Manapov, Farkhad (2017): Concurrent Afatinib and Whole-Brain Radiotherapy in Exon 19-del-EGFR Mutant Lung Adenocarcinoma: A Case Report and Mini Review of the Literature. In: Frontiers in Oncology, Bd. 7, 88 [PDF, 947kB]

Manapov, Farkhad; Roengvoraphoj, Olarn und Eze, Chukwuka (2017): Why is survival after pembrolizumab affected by previous radiotherapy? In: Lancet Oncology, Bd. 18, Nr. 9, E504-E504

Eze, Chukwuka; Roengvoraphoj, Olarn; Dantes, Maurice und Manapov, Farkhad (2017): Is it time to convert the frequency of radiotherapy in small-cell lung cancer? In: Lancet Oncology, Bd. 18, Nr. 10, E555-E555

Roengvoraphoj, Olarn; Eze, Chukwuka; Niyazi, Maximilian; Li, Minglun; Hildebrandt, Guido; Fietkau, Rainer; Belka, Claus und Manapov, Farkhad (2017): Prognostic role of patient gender in limited-disease small-cell lung cancer treated with chemoradiotherapy. In: Strahlentherapie und Onkologie, Bd. 193, Nr. 2: S. 150-155

Manapov, Farkhad; Roengvoraphoj, Olarn; Li, Minglun und Eze, Chukwuka (2017): Moderate hypofractionated image-guided thoracic radiotherapy for locally advanced node-positive non-small cell lung cancer patients with very limited lung function: a case report. In: Radiation Oncology Journal, Bd. 35, Nr. 2: S. 180-184 [PDF, 390kB]

Eze, Chukwuka; Roengvoraphoj, Olarn und Manapov, Farkhad (2017): Prophylactic Cranial Irradiation in Resected Early-Stage Small Cell Lung Cancer. In: International Journal of Radiation Oncology Biology Physics, Bd. 98, Nr. 3: S. 612-614

Manapov, Farkhad; Eze, Chukwuka; Niyazi, Maximilian; Roengvoraphoj, Olarn; Li, Minglun; Hegemann, Nina-Sophie; Hildebrandt, Guido; Fietkau, Rainer und Belka, Claus (2016): Investigating a Correlation between Chemoradio-therapy Schedule Parameters and Overall Survival in a real-life LD SCLC Patient Cohort. In: Journal of Cancer, Bd. 7, Nr. 14: S. 2012-2017

Manapov, Farkhad; Niyazi, Maximilian; Gerum, Sabine; Roengvoraphoj, Olarn; Eze, Chukwuka; Li, Minglun; Hildebrandt, Guido; Fietkau, Rainer; Klautke, Gunther und Belka, Claus (2016): Evaluation of the role of remission status in a heterogeneous limited disease small-cell lung cancer patient cohort treated with definitive chemoradiotherapy. In: BMC Cancer 16:216 [PDF, 757kB]

Diese Liste wurde am Sat Apr 13 23:44:38 2024 CEST erstellt.